Home › COPD › Virginia › Arlington
COPD clinical trials in Arlington, VA
5 studies for COPD are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Recruiting
- Inova Fairfax Hospital, Falls Church · 4 mi away
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
RecruitingPhase 3
- Research Site, Potomac · 11 mi away
COPD Exacerbation Follow Up
RecruitingObservational study
- Inova Fairfax Hospital, Falls Church · 4 mi away
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
RecruitingPhase 2
- Burke Internal Medicine, Inc., Burke · 11 mi away
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Recruiting
- Inova Health Care Services, Falls Church · 4 mi away
About COPD
COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.
More about COPD on MedlinePlus
COPD trials in other cities
- Philadelphia, PA22 studies
- Birmingham, AL18 studies
- Miami, FL18 studies
- Boston, MA17 studies
- Houston, TX15 studies
- Orlando, FL15 studies
- Chicago, IL14 studies
- Pittsburgh, PA13 studies
- Baltimore, MD13 studies
- Dallas, TX12 studies
- New York City, NY11 studies
- Ann Arbor, MI10 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer104 studies
- Metastatic Cancer53 studies
- Colorectal Cancer52 studies
- Cancer (all types)49 studies
- Breast Cancer46 studies
- Ovarian Cancer45 studies
- Lung Cancer40 studies
- Endometrial Cancer38 studies
- Pancreatic Cancer34 studies
- Head and Neck Squamous Cell Carcinoma25 studies
- Small Cell Lung Cancer23 studies
- Triple-Negative Breast Cancer20 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.